期刊文献+

糖尿病对股腘动脉支架患者预后影响的临床研究 被引量:2

Impact of diabetes mellitus on outcomes of patients with femoropopliteal artery stenting
原文传递
导出
摘要 目的 探讨糖尿病对下肢动脉硬化闭塞症患者行股腘动脉支架置入术后支架通畅率及临床预后的影响.方法 回顾性总结2006年1月至2012年12月在首都医科大学宣武医院血管外科成功接受股腘动脉支架成形术治疗的下肢动脉硬化闭塞症患者的临床资料,分成糖尿病组和非糖尿病组,对比分析2组患者术后的支架一期通畅率、辅助通畅率、保肢率和生存率.结果 本研究入组患者291例(332条肢体),糖尿病组患者193例(214条肢体),非糖尿病组患者98例(118条肢体).平均随访(34±18)个月.患者术后5年的支架总体一期通畅率、辅助通畅率、保肢率及生存率分别为23.2%、35.3%、89.2%和69.6%.单因素分析显示,糖尿病患者术后5年的支架一期通畅率、保肢率及生存率均低于非糖尿病患者,但2组患者支架的辅助通畅率差异无统计学意义.Cox多因素回归分析证实,女性患者支架的一期通畅率低于男性,严重膝下血管病变和高血压与保肢率降低有关,而年龄则是影响患者生存率的唯一独立因素.结论 糖尿病是影响股腘动脉支架一期通畅率、保肢率和生存率的危险因素,但不是独立危险因素. Objective To analyze the influence of diabetes mellitus (DM) on the outcomes of percutaneous transluminal angioplasty (PTA) with stenting of femoropopliteal artery,in patients with atherosclerotic occlusive disease (ASO).Method Clinical data of inpatients who successfully received PTA with stenting procedures of femoropopliteal artery in Xuanwu Hospital from January 2006 to December 2012 were analyzed retrospectively.Patients were stratified into DM and non-DM groups.Results were compared between the two groups including primary patency (PP),assisted patency (AP),limb salvage and survival using Kaplan-Meier life table and Cox regression analyses.Result Totally 291 patients underwent 332 procedures.There were 214 DM and 118 non-DM limbs.Mean follow-up was 34 months.The 5-year PP was 23.2%,AP was 35.3%,limb salvage was 89.2%,and survival was 69.6%.DM was associated with lower 5-year PP,limb salvage,and survival than non-DM.But there were no significant difference in AP between the two groups.Females were associated with decreased PP than males on Cox multivariate analysis.Hypertension and below tibial diseases were associated with lower limb salvage rate and age is the only predictor of survival rate.Conclusions DM is a risk factor for poor outcomes after PTA with stenting procedures.
出处 《中华普通外科杂志》 CSCD 北大核心 2014年第8期580-583,共4页 Chinese Journal of General Surgery
基金 北京市科学技术委员会资助项目(Z121100005512009,Z131107002213041)
关键词 闭塞性动脉硬化 支架 糖尿病 预后 Arteriosclerosis obliterans Stents Diabetes mellitus Prognosis
  • 相关文献

参考文献11

  • 1Dormandy J,Heeck L,Vig S.The fate of patients with critical leg ischemia[J].Semin Vasc Surg,1999,12(2):142-147.
  • 2Sheetz MJ,King GL.Molecular understanding of hyperglycemia's adverse effects for diabetic complications[J].JAMA,2002,288(20):2579-2588.
  • 3叶炜,刘昌伟,李拥军,郑月宏,吴继东,刘暴,曾嵘,吴巍巍,宋小军,管珩.老年人下肢动脉硬化闭塞症腔内治疗效果分析[J].中华外科杂志,2010,48(4):261-264. 被引量:22
  • 4DeRubertis BG,Pierce M,Ryer EJ,et al.Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia[J].J Vasc Surg,2008,47 (1):1 01-108.
  • 5Clark TW,Groffsky JL,Soulen MC.Predictors of long-term patency after femoropopliteal angioplasty:results from the STAR registry[J].J Vasc Interv Radiol,2001,12(8):923-933.
  • 6Iida O,Uematsu M,Soga Y,et al.Timing of the restenosis following nitinol stenting in the superficial femoral artery and the factors associated with early and late restenoses[J].Catheter Cardiovasc Interv,2011,78(4):611-617.
  • 7Abularrage CJ,Conrad MF,Hackney LA,et al.Long-term outcomes of diabetic patients undergoing endovascular infrainguinal interventions[J].J Vasc Surg,2010,52 (2):314-322.
  • 8Conrad MF,Cambria RP,Stone DH,et al.Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease:a contemporary series[J].J Vasc Surg,2006,44(4):762-769.
  • 9Surowiec SM,Davies MG,Eberly SW,et al.Percutaneous angioplasty and stenting of the superficial femoral artery[J].J Vasc Surg,2005,41 (2):269-278.
  • 10Bakken AM,Palchik E,Hart JP,et al.Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions[J].J Vasc Surg,2007,46(5):946-958.

二级参考文献7

  • 1罗小云,吴庆华,陈忠.动脉硬化性主髂动脉闭塞症血管重建的术式选择[J].中华普通外科杂志,2006,21(2):102-104. 被引量:13
  • 2刘昌伟,刘暴,叶炜,管珩,郑月宏,李拥军,曾嵘,倪冷,邵江,唐峰.重症下肢缺血的血管腔内治疗[J].中国医学科学院学报,2007,29(1):33-36. 被引量:13
  • 3Hirsch AT, Haskal Z J, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease. Circulation ,2006,113 : e463-654.
  • 4Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease ( TASC Ⅱ ). J Vase Surg,2007,45 Suppl S:S5-67.
  • 5Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus ( TASC). J Vasc Surg,2000,31 :S1-S296.
  • 6Raghunathan A, Rapp JH, Littooy F, et al. Postoperative outcomes for patients undergoing elective revascularization for critical limb ischemia and intermittent claudication: a subanalysis of the Coronary Artery Revascularization Prophylaxis ( CARP ) trial. J Vasc Surg,2006,43:1175-1182.
  • 7刘昌伟.股腘动脉硬化闭塞症治疗方法的合理选择及评价[J].中国实用外科杂志,2008,28(10):842-844. 被引量:9

共引文献21

同被引文献17

  • 1Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II) [J]. J Vase Surg, 2007, 45(Suppl S): $5-67.
  • 2Singh GD, Armstrong E J, Laird JR. Femoropopli.teal in-stent restenosis: current treatment strategies [J]. J Cardiovasc Surg (Torino), 2014, 55(3): 325-333.
  • 3Baril DT, Rhee RY, Kim J, et al. Duplex criteria for determination of in-stent stenosis after angioplasty and stenting of the superficial femoral artery [J]. J Vase Surg, 2009, 49(1): 133-138.
  • 4Aghel A, Armstrong EJ. Recent advances in self-expanding stents for use in the superficial femoral and popliteal arteries [J]. Expert Rev Cardiovasc Ther, 2014, 12(7): 833-842.
  • 5Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. Trans Atlantic Inter-Society Consensus (TASC) [J]. J Vase Surg, 2000, 31(lpt 2): S1-$296.
  • 6Krankenberg H, Ttibler T, Sixt S, et al. German multicenter real-world registry of stenting for superficial femoral artery disease: clinical results and predictive factors for revascularization [J]. J Endovasc Ther, 2014, 21(4): 463-471.
  • 7Sultan S, Tawfick W, Hynes N. Ten-year technical and clinical outcomes in TransAtlantic Inter-Society Consensus II infrainguinalC/D lesionss using duplex ultrasound arterial mapping as the sole imaging modality for critical lower limb isehemia [J]. J Vase Surg, 2013, 57(4): 1038-1045.
  • 8Bosiers M, Torsello G, Gissler HM, et al. Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study [J]. J Endovasc Ther, 2009, 16(3): 261-269.
  • 9Matsumura JS, Yamanouchi D, Goldstein JA, et al. The united states study for evaluating endovascular treatments of lesions in the superficial femoral artery and proximal popliteal by using the prot6g6 everflex nitinol stent system II (DURABILITY II) [J]. J Vasc Surg, 2013, 58(1): 73-83.
  • 10Schillinger M, Sabeti S, Dick P, et aL Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting [J]. Circulation, 2007, 115(21): 2745-2749.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部